GAUCHER'S DISEASE TYPE III

Clinical trials for GAUCHER'S DISEASE TYPE III explained in plain language.

Never miss a new study

Get alerted when new GAUCHER'S DISEASE TYPE III trials appear

Sign up with your email to follow new studies for GAUCHER'S DISEASE TYPE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Pill vs. infusion: new hope for rare neurological disease

Disease control Ongoing

This study is testing if a daily oral pill called venglustat can work as well as the current standard of care—biweekly intravenous infusions—for maintaining stability in people with Gaucher disease type 3. It involves about 43 adults and teenagers (12+) who are already stable on …

Matched conditions: GAUCHER'S DISEASE TYPE III

Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

GAUCHER'S DISEASE TYPE III

Get alerted when new GAUCHER'S DISEASE TYPE III trials appear

Pill vs. infusion: new hope for rare neurological disease